Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$12.75−0.40 (-3.04%)
Close on Nov 16, 2026Market cap $86.56MP/E –Yield –
Eloxx Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Eloxx Pharmaceuticals's ebitda for the twelve months ending Jun 30, 2016 was -$11.10M. For fiscal 2016 it was -$11.10M. The highest annual figure on record is -$4.36M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | -$11.10M | – |
| FY2015 | Jun 30, 2015 | -$17.90M | – |
| FY2014 | Jun 30, 2014 | -$8.80M | – |
| FY2013 | Jun 30, 2013 | -$4.36M | – |
| FY2012 | Jun 30, 2012 | -$5.15M | – |
| FY2011 | Jun 30, 2011 | -$7.78M | – |
| FY2010 | Jun 30, 2010 | -$4.72M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$1.38M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$4.87M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$3.73M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$1.12M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$880.91K | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$1.19M | – |
| Q2 FY2015CQ4 2014 | Dec 31, 2014 | -$10.71M | – |
| Q1 FY2015CQ3 2014 | Sep 30, 2014 | -$5.13M | – |
| Q4 FY2014CQ2 2014 | Jun 30, 2014 | -$3.57M | – |
| Q3 FY2014CQ1 2014 | Mar 31, 2014 | -$2.04M | – |
See a number that looks wrong?